Task: Answer Verification
Input (English): Question: Does kRAS mutation predict the efficacy of neo-adjuvant chemoradiotherapy in rectal cancer : a systematic review and meta-analysis?
Answer: Based on these data, the presence of KRAS mutation does not affect tumor down-staging or cancer specific survival following neo-adjuvant CRT and surgery for rectal cancer.
Output (English): no